Question 27 The following pharmacokinetic data for N-acetylprocainamide (NAPA) were obtained in a Phase 1 study in volun

Business, Finance, Economics, Accounting, Operations Management, Computer Science, Electrical Engineering, Mechanical Engineering, Civil Engineering, Chemical Engineering, Algebra, Precalculus, Statistics and Probabilty, Advanced Math, Physics, Chemistry, Biology, Nursing, Psychology, Certifications, Tests, Prep, and more.
Post Reply
answerhappygod
Site Admin
Posts: 899603
Joined: Mon Aug 02, 2021 8:13 am

Question 27 The following pharmacokinetic data for N-acetylprocainamide (NAPA) were obtained in a Phase 1 study in volun

Post by answerhappygod »

Question 27 The Following Pharmacokinetic Data For N Acetylprocainamide Napa Were Obtained In A Phase 1 Study In Volun 1
Question 27 The Following Pharmacokinetic Data For N Acetylprocainamide Napa Were Obtained In A Phase 1 Study In Volun 1 (45.21 KiB) Viewed 76 times
Question 27 The following pharmacokinetic data for N-acetylprocainamide (NAPA) were obtained in a Phase 1 study in volunteers with normal kidney function: • Elimination half-life: 6.2 h. • Elimination clearance: 233 mL/min. • % Renal excretion: 75.8% Estimate the elimination clearance of NAPA that would be expected for a patient with a creatinine clearance of 50 mL/min. Assume that a creatinine clearance of 100 mL/min is the value for individuals with normal kidney function. 8.7 L/h 5.3 L/h 7.0 L/h 1 pts 17.4 L/h 28 L/h
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!
Post Reply